- Business
- Childbirth & Education
- Legal Formalities
- Motoring
- Other
- Pensions & Benefits
- Property & Accommodation
- Taxes
- Airports and Airlines Spain
- Paramount Theme Park Murcia Spain
- Corvera International Airport Murcia Spain
- Join us for Tea on the Terrace
- When Expat Eyes Are Smiling
- Meet Wincham at The Homes, Gardens & Lifestyle Show, Calpe
- QROPS 2014
- Spain Increases IHT in Valencia & Murcia
- Removals to Spain v Exports from Spain
- The Charm of Seville
- Gibraltar Relations
- Retiro Park : Madrid
- Community Insurance in Spain
- Calendar Girls
- Considerations when Insuring your Boat in Spain
- QROPS – HMRC Introduces changes that create havoc in the market place
- QROPS – All Change From April 2012
- Liva & Laia : 15th November

Spain's drug sector lobby group is ready to accept state-guaranteed securities from regional governments to cover 5.83 billion euros in unpaid bills for drugs supplied to public hospitals.
Spain's regional governments, which control health and education, are struggling to pay suppliers following the collapse of the real estate boom which slashed their tax revenue and froze access to capital markets.
"The industry is prepared to consider a solution (to the unpaid debt) of issuing government-backed securities," industry group Farmaindustria said on Wednesday.
Farmaindustria represents companies including the Spanish units of Roche Holding AG and Novartis AG.
Farmaindustria managing director Humberto Arnes told journalists each drug company and each region should make its own decision on securitising outstanding debts.
Spain's central government is currently paying about 5.6% to borrow for 10 years, as the euro zone debt crisis continues to hammer the peripheral countries.
The regional governments are, on average, paying their bills 468 days late compared with 390 days a year ago, according to Farmaindustria data.
Farmaindustria chairman Jordi Ramentol said many companies risked folding because of unpaid debts and the impact of swingeing price cuts implemented by the outgoing Socialist government. Sector sales are seen dropping 9% this year and 10% in 2012.
Pharmaceutical companies hope relations will improve with the new centre-right People's Party government, Ramentol said.